Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-09-14

Clinical Trial Update: PEP005 Gel - Evaluation of Local Tolerability After Exposure to Ingenol Mebutate Gel Followed by Hand Washing in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating local tolerability of ingenol mebutate gel (PEP005 Gel) after exposure followed by hand washing in healthy subjects, with actinic kerat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PEP005 Gel (ingenol mebutate)

Snippet

Sponsor: Peplin | Conditions: Healthy, Actinic Keratosis | Phase 1 | Status: COMPLETED